The reversed halo sign: Pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?

Clinical Infectious Diseases

Volumn 58, Issue 5, 2014, Pages 672-678

  Legouge, C ^a   Caillot, D ^a,d   Chretien M L ^a,d   Lafon, I ^a   Ferrant, E ^a   Audia, S ^b   Pages P B ^b   Roques, M ^a   Estivalet, L ^b   Martin, L ^b   Maitre, T ^b   Bastie, J N ^a,b   Dalle, F ^c  

^a HÔPITAL DU BOCAGE   (France)

^b Department of Internal Medicine ^*  (United States)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d INSERM   (France)

Author keywords

computed tomography; leukemia; mucormycosis; neutropenia; reversed halo sign

Indexed keywords

ADULT; AGED; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HUMAN; LEUKEMIA; LUNG; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; MUCORMYCOSIS; NEUTROPENIA; PATHOLOGY; RADIOGRAPHY; RETROSPECTIVE STUDY;

ADULT; AGED; FEMALE; HUMANS; LEUKEMIA; LUNG; LUNG DISEASES, FUNGAL; MALE; MIDDLE AGED; MUCORMYCOSIS; NEUTROPENIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84894286174     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit929     Document Type: Article

References (40)

1. Kwon-Chung KJ. Taxonomy of fungi causing mucormycosis and entomophthoramycosis (zygomycosis) and nomenclature of the disease: molecular mycologic perspectives. Clin Infect Dis 2012; 54(suppl 1): S8-15.
2. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012; 54(suppl 1):S23-34.
3. Pagano L, Offidani M, Fianchi L, et al. Mucormycosis in hematologic patients. Haematologica 2004; 89:207-14.
4. Chamilos G, Luna M, Lewis RE, et al. Invasive fungal infections in patients with hematologic malignancies in a tertiary care cancer center: an autopsy study over a 15-year period (1989-2003). Haematologica 2006; 91:986-9.
5. Roden MM, Zaoutis TE, Buchanan WL, et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41:634-53.
6. Skiada A, Pagano L, Groll A, et al. Zygomycosis in Europe: analysis of 230 cases accrued by the registry of the European Confederation of Medical Mycology (ECMM) Working Group on Zygomycosis between 2005 and 2007. Clin Microbiol Infect Dis 2011; 17:1859-67.
7. Pagano L, Caira M, Candoni A, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006; 91:1068-75.
8. Torres-Narbona M, Guinea J, Martínez-Alarcón J, Muñoz P, Gadea I, Bouza E. Impact of zygomycosis on microbiology workload: a survey study in Spain. J Clin Microbiol 2007; 45:2051-3.
9. Heussel CP, Kauczor HU, Heussel GE, et al. Pneumonia in febrile neutropenic patients and in bone marrow and blood stem-cell transplant recipients: use of high-resolution computed tomography. J Clin Oncol 1999; 17:796-805.
10. Gompelmann D, Heussel CP, Schuhmann M, Herth FJF. The role of diagnostic imaging in the management of invasive fungal diseases-report from an interactive workshop. Mycoses 2011; 54(suppl 1):27-31.
11. Caillot D, Casasnovas O, Bernard A, et al. Improved management of invasive pulmonary aspergillosis in neutropenic patients using early thoracic computed tomographic scan and surgery. J Clin Oncol 1997; 15:139-47.
12. Austin JH, Müller NL, Friedman PJ, et al. Glossary of terms for CT of the lungs: recommendations of the Nomenclature Committee of the Fleischner Society. Radiology 1996; 200:327-31.
13. Caillot D, Couaillier JF, Bernard A, et al. Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia. J Clin Oncol 2001; 19:253-9.
14. Voloudaki AE, Bouros DE, Froudarakis ME, Datseris GE, Apostolaki EGGourtsoyiannis NC. Crescentic and ring-shaped opacities. CT features in two cases of bronchiolitis obliterans organizing pneumonia (BOOP). Acta Radiol Stockh Swed 1987 1996; 37:889-92.
15. Vogl TJ, Hinrichs T, Jacobi V, Böhme A, Hoelzer D. Computed tomographic appearance of pulmonary mucormycosis [in German]. Rofo 2000; 172:604-8.
16. Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on high-resolution CT of cryptogenic organizing pneumonia: diagnostic implications. AJR Am J Roentgenol 2003; 180:1251-4.
17. Polverosi R, Maffesanti M, Dalpiaz G. Organizing pneumonia: typical and atypical HRCT patterns. Radiol Med 2006; 111:202-12.
18. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Müller NL, Remy J. Fleischner Society: glossary of terms for thoracic imaging. Radiology 2008; 246:697-722.
19. Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP. Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 2005; 41:60-6.
20. Wahba H, Truong MT, Lei X, Kontoyiannis DP, Marom EM. Reversed halo sign in invasive pulmonary fungal infections. Clin Infect Dis 2008; 46:1733-7.
21. Lanternier F, Dannaoui E, Morizot G, et al. A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007). Clin Infect Dis 2012; 54(suppl 1):S35-43.
22. Chamilos G, Lewis RE, Kontoyiannis DP. Delaying amphotericin Bbased frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis. Clin Infect Dis 2008; 47:503-9.
23. Voigt K, Cigelnik E, O'donnell K. Phylogeny and PCR identification of clinically important Zygomycetes based on nuclear ribosomal-DNA sequence data. J Clin Microbiol 1999; 37:3957-64.
24. De Pauw B,Walsh TJ, Donnelly JP, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46:1813-21.
25. Segal BH, Herbrecht R, Stevens DA, et al. Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria. Clin Infect Dis 2008; 47:674-83.
26. Skiada A, Lanternier F, Groll AH, et al. Diagnosis and treatment of mucormycosis in patients with hematological malignancies: guidelines from the 3rd European Conference on Infections in Leukemia (ECIL 3). Haematologica 2012; 98:492-504.
27. Busca A, Limerutti G, Locatelli F, Barbui A, De Rosa FG, Falda M. The reversed halo sign as the initial radiographic sign of pulmonary zygomycosis. Infection 2012; 40:77-80.
28. Leutner CC, Gieseke J, Lutterbey G, et al. MR imaging of pneumonia in immunocompromised patients: comparison with helical CT. AJR Am J Roentgenol 2000; 175:391-7.
29. Chamilos G, Macapinlac HA, Kontoyiannis DP. The use of 18F-fluorodeoxyglucose positron emission tomography for the diagnosis and management of invasive mould infections. Med Mycol 2008; 46:23-9.
30. Hot A, Maunoury C, Poiree S, et al. Diagnostic contribution of positron emission tomography with [18F]fluorodeoxyglucose for invasive fungal infections. Clin Microbiol Infect 2011; 17:409-17.
31. Walsh TJ, Gamaletsou MN, McGinnis MR, Hayden RT, Kontoyiannis DP. Early clinical and laboratory diagnosis of invasive pulmonary, extrapulmonary, and disseminated mucormycosis (zygomycosis). Clin Infect Dis 2012; 54(suppl 1):S55-60.
32. Potenza L, Vallerini D, Barozzi P, et al. Mucorales-specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients. Blood 2011; 118: 5416-9.
33. Marom EM, Kontoyiannis DP. Imaging studies for diagnosing invasive fungal pneumonia in immunocompromised patients. Curr Opin Infect Dis 2011; 24:309-14.
34. Georgiadou SP, Sipsas NV, Marom EM, Kontoyiannis DP. The diagnostic value of halo and reversed halo signs for invasive mold infections in compromised hosts. Clin Infect Dis 2011; 52:1144-55.
35. Okubo T, Miyazaki E, Ueo M, et al. A case of psittacosis with wandering infiltrates developing to acute respiratory distress syndrome [in Japanese]. Nihon Koky?ki Gakkai Zasshi J Jpn. Respir Soc 2007; 45: 419-23.
36. Cunha BA. Legionnaires' disease: clinical differentiation from typical and other atypical pneumonias. Infect Dis Clin North Am 2010; 24: 73-105.
37. Marchiori E, Grando RD, Simões Dos Santos CE, et al. Pulmonary tuberculosis associated with the reversed halo sign on high-resolution CT. Br J Radiol 2010; 83:e58-60.
38. Kumazoe H, Matsunaga K, Nagata N, et al. 'Reversed halo sign' of high-resolution computed tomography in pulmonary sarcoidosis. J Thorac Imaging 2009; 24:66-8.
39. Marr KA, Carter RA, Crippa F, Wald A, Corey L. Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34:909-17.
40. Pagano L, Girmenia C, Mele L, et al. Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 2001; 86:862-70.